Field & Main Bank Has $251,000 Holdings in CVS Health Co. (NYSE:CVS)

Field & Main Bank lowered its stake in CVS Health Co. (NYSE:CVS) by 30.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 3,185 shares of the pharmacy operator’s stock after selling 1,409 shares during the quarter. Field & Main Bank’s holdings in CVS Health were worth $251,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Exchange Traded Concepts LLC boosted its holdings in shares of CVS Health by 22.8% during the 3rd quarter. Exchange Traded Concepts LLC now owns 5,993 shares of the pharmacy operator’s stock worth $418,000 after buying an additional 1,112 shares during the period. Brookstone Capital Management lifted its position in CVS Health by 18.3% during the 3rd quarter. Brookstone Capital Management now owns 60,115 shares of the pharmacy operator’s stock worth $4,245,000 after acquiring an additional 9,303 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in shares of CVS Health by 1.0% in the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 335,419 shares of the pharmacy operator’s stock valued at $23,419,000 after purchasing an additional 3,400 shares during the last quarter. Sheets Smith Wealth Management increased its stake in shares of CVS Health by 10.4% in the third quarter. Sheets Smith Wealth Management now owns 63,875 shares of the pharmacy operator’s stock worth $4,460,000 after purchasing an additional 6,009 shares during the period. Finally, Sweet Financial Partners LLC lifted its position in shares of CVS Health by 60.2% during the 3rd quarter. Sweet Financial Partners LLC now owns 20,971 shares of the pharmacy operator’s stock worth $1,464,000 after purchasing an additional 7,877 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS traded up $0.26 during trading hours on Monday, hitting $67.44. The stock had a trading volume of 6,556,157 shares, compared to its average volume of 10,605,164. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a market capitalization of $85.01 billion, a price-to-earnings ratio of 10.44, a P/E/G ratio of 0.89 and a beta of 0.52. CVS Health Co. has a 52 week low of $64.41 and a 52 week high of $83.25. The company’s fifty day moving average is $74.22 and its two-hundred day moving average is $73.65.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter in the previous year, the company posted $1.99 EPS. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, analysts anticipate that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.94%. CVS Health’s dividend payout ratio (DPR) is currently 41.18%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CVS. Piper Sandler upped their price target on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Royal Bank of Canada reduced their price target on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research report on Wednesday, April 10th. Barclays initiated coverage on CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target on the stock. Finally, Wells Fargo & Company reduced their price objective on CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.

Insider Buying and Selling

In other news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.24% of the stock is currently owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.